Clinical Trial Update: Ramosetron Pre-treatment for PONV and QT Prolongation [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating Ramosetron as pre-treatment for postoperative nausea and vomiting and QT prolongation, with the study status reported as completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Long Qt Syndrome
• Postoperative Nausea and Vomiting

Drugs mentioned

• Ramosetron (ramosetron)

Snippet

Sponsor: Konkuk University Medical Center | Conditions: PONV, Prolonged QTc Interval | Phase 4 | Status: COMPLETED